140 related articles for article (PubMed ID: 3220617)
1. Single dose kinetics of rifampicin and isoniazid in well-nourished and malnourished patients of tuberculosis.
Garg SK; Dhand R; Malik SK; Kalra S; Gupta PH; Jha VK; Shukla VK; Lal R
Int J Clin Pharmacol Ther Toxicol; 1988 Aug; 26(8):417-20. PubMed ID: 3220617
[TBL] [Abstract][Full Text] [Related]
2. Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels.
Agrawal S; Singh I; Kaur KJ; Bhade SR; Kaul CL; Panchagnula R
Int J Pharm; 2004 May; 276(1-2):41-9. PubMed ID: 15113612
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetic interaction of ketoconazole, isoniazid and rifampicin].
Pilheu JA; Galati MR; Yunis AS; De Salvo MC; Negroni R; García Fernández JC; Mingolla L; Rubio MC; Masana M; Acevedo C
Medicina (B Aires); 1989; 49(1):43-7. PubMed ID: 2698437
[TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetic factors and bioavailability of rifampicin, isoniazid and pyrazinamid fixed in one dose capsule.
Zwolska Z; Augustynowicz-Kopeć E; Niemirowska-Mikulska H
Acta Pol Pharm; 2002; 59(6):448-52. PubMed ID: 12669769
[TBL] [Abstract][Full Text] [Related]
5. [Adjusting or not adjusting isoniazid dosage?].
Parrot R; Boval C; Grosset J; Gaillard JP
Rev Fr Mal Respir; 1983; 11(5):705-12. PubMed ID: 6658156
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
Ribera E; Azuaje C; Lopez RM; Domingo P; Curran A; Feijoo M; Pou L; Sánchez P; Sambeat MA; Colomer J; Lopez-Colomes JL; Crespo M; Falcó V; Ocaña I; Pahissa A
J Antimicrob Chemother; 2007 Apr; 59(4):690-7. PubMed ID: 17307771
[TBL] [Abstract][Full Text] [Related]
7. [Significance of the acetylator phenotype and initial oral/intravenous rifampicin administration in the treatment of tuberculosis].
Loos U; Musch E; Schwabe HK
Pneumologie; 1990 Feb; 44 Suppl 1():488-9. PubMed ID: 2367445
[TBL] [Abstract][Full Text] [Related]
8. Malabsorption of rifampin and isoniazid in HIV-infected patients with and without tuberculosis.
Gurumurthy P; Ramachandran G; Hemanth Kumar AK; Rajasekaran S; Padmapriyadarsini C; Swaminathan S; Venkatesan P; Sekar L; Kumar S; Krishnarajasekhar OR; Paramesh P
Clin Infect Dis; 2004 Jan; 38(2):280-3. PubMed ID: 14699462
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability of isoniazid, rifampicin and pyrazinamide (in free combination or fixed-triple formulation) in intermittent antituberculous chemotherapy.
Acocella G; Luisetti M; Grassi GG; Peona V; Pozzi E; Grassi C
Monaldi Arch Chest Dis; 1993; 48(3):205-9. PubMed ID: 8369784
[TBL] [Abstract][Full Text] [Related]
10. [Clinico-pharmacological approach to rifampicin and isoniazid dosage].
Karkishchenko NN; Khoron'ko VV; Vorob'ev VS; Anisimova NB; Chubarian VT
Probl Tuberk; 1987; (9):31-4. PubMed ID: 3422964
[No Abstract] [Full Text] [Related]
11. Bioavailability of rifampicin, isoniazid and pyrazinamide from fixed-dose combination capsules.
Zwolska Z; Niemirowska-Mikulska H; Augustynowicz-Kopec E; Walkiewicz R; Stambrowska H; Safianowska A; Grubek-Jaworska H
Int J Tuberc Lung Dis; 1998 Oct; 2(10):824-30. PubMed ID: 9783530
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of isoniazid in pulmonary tuberculosis--a comparative study at two dose levels.
Roy V; Tekur U; Chopra K
Indian Pediatr; 1996 Apr; 33(4):287-91. PubMed ID: 8772902
[TBL] [Abstract][Full Text] [Related]
13. [Simultaneous study of the induction effect of rifampicin and the phenotype for acetylation of isoniazid in 21 patients with tuberculosis undergoing a combination treatment].
Chailleux E; Ordronneau J; Le Normand Y; Kergueris MF; Larousse C
Rev Fr Mal Respir; 1980; 8(3):219-24. PubMed ID: 7187065
[TBL] [Abstract][Full Text] [Related]
14. [Results of examination in healthy volunteers of rifampicin and isoniazid bioavailability from Polish two-drug combination capsules of rifamazid used for tuberculosis treatment].
Zofia Z; Niemirowska-Mikulska H; Augustynowicz-Kopeć E; Stambrowska A
Pneumonol Alergol Pol; 1998; 66(3-4):198-206. PubMed ID: 9857665
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability of rifampicin, isoniazid and pyrazinamide in a triple drug formulation: comparison of plasma and urine kinetics.
Gurumurthy P; Ramachandran G; Vijayalakshmi S; Kumar AK; Venkatesan P; Chandrasekaran V; Vjayasekaran V; Kumaraswami V; Prabhakar R
Int J Tuberc Lung Dis; 1999 Feb; 3(2):119-25. PubMed ID: 10091876
[TBL] [Abstract][Full Text] [Related]
16. [Antibacterian activity modifications of serum isoniazid when using it with rifampicin (author's transl)].
Nouhouayi A; Bergogne-Berezin E; Lafaix C
Pathol Biol (Paris); 1982 Jun; 30(6):389-93. PubMed ID: 7050848
[TBL] [Abstract][Full Text] [Related]
17. Bioequivalence study of rifampicin in fixed-dose combination of rifampicin and isoniazid vs. separate formulations.
Panchagnula R; Singh I; Kaur KJ; Kaul CL
Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):625-8. PubMed ID: 10669909
[TBL] [Abstract][Full Text] [Related]
18. Serum concentrations of rifampicin and isoniazid in tuberculosis.
Seth V; Beotra A; Seth SD; Semwal OP; Kabra S; Jain Y; Mukhopadhya S
Indian Pediatr; 1993 Sep; 30(9):1091-8. PubMed ID: 8125594
[TBL] [Abstract][Full Text] [Related]
19. Serum concentration of isoniazid following administration of the drug alone and in combination with rifampicin in patients of pulmonary tuberculosis.
Singhal KC; Rathi R; Kishore K; Varshney SC; Varshney DP
Indian J Physiol Pharmacol; 1986; 30(1):115-7. PubMed ID: 3818028
[No Abstract] [Full Text] [Related]
20. [Plasma levels of rifampicin and isoniazid and serum levels of aminotransferases in combined tuberculostatic treatment (author's transl)].
Knop P; Kindler U; Austerhoff A
Dtsch Med Wochenschr; 1977 Dec; 102(52):1913-5. PubMed ID: 598300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]